skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vivo distribution of liposome encapsulated hemoglobin studied with imaging radiotracers. Progress report

Technical Report ·
OSTI ID:7063045

This project has as its objective the development of radiotracer imaging technology to follow the in vivo circulation and organ deposition of liposome encapsulated hemoglobin (LEH). LEH will be labeled with technetium-99m or indium-111 and infused into small animals to monitor any in vivo differences between different LEH formulations. These studies will be correlated with any hematological and pathological changes associated with LEH treatment. Development of such non-invasive monitoring techniques may lead to significant cost effective manufacturing and formulation improvements, and ultimately a more efficacious LEH product. The development of this elegant labeling technique should make it possible to study the effect of various LEH modifications on biodistribution non-invasively in primates and humans.

Research Organization:
Texas Univ., San Antonio, TX (United States)
OSTI ID:
7063045
Report Number(s):
AD-A-258750/9/XAB; CNN: N00014-91-J-1217
Country of Publication:
United States
Language:
English

Similar Records

In vivo biodistribution of a radiolabeled blood substitute: sup 99m Tc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit
Journal Article · Sun Dec 01 00:00:00 EST 1991 · Proceedings of the National Academy of Sciences of the United States of America; (United States) · OSTI ID:7063045

In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5'-phosphate
Journal Article · Wed Feb 01 00:00:00 EST 1989 · J. Lab. Clin. Med.; (United States) · OSTI ID:7063045

First In Vivo Evaluation of Liposome-encapsulated 223Ra as a Potential Alpha-particle-emitting Cancer Therapeutic Agent
Journal Article · Wed Sep 13 00:00:00 EDT 2006 · Anticancer Research: international journal of cancer research and treatment, 26(2841-2848 · OSTI ID:7063045